Piramal Enterprises Ltd.
SET SMS ALERT| 5-Day | 10,579 |
| 10-Day | 12,865 |
| 30-Day | 11,513 |
| 5-Day | 10,579 |
| 10-Day | 12,865 |
| 30-Day | 11,513 |
Depth
Market Depth (24 Jun 2018)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 90 | 2606.00 | 2610.00 | 50 |
| 100 | 2605.05 | 2615.20 | 1 |
| 100 | 2602.00 | 2618.50 | 4 |
| 20 | 2600.00 | 2618.95 | 2 |
| 1 | 2598.25 | 2619.00 | 16 |
| 1379 | Total | 314 | Total |
Buy Qty
1379
Sell QTY
314
| 5-Day | 374,089 |
| 10-Day | 291,669 |
| 30-Day | 228,125 |
| 5-Day | 374,089 |
| 10-Day | 291,669 |
| 30-Day | 228,125 |
- Quote
- CHARTS
- NEWS
- COMMENTS1 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Top Trading Ideas
22 June 2018
buy BajajFinance Jun Fut |
Entry Price (Rs) 2,276.40 |
Exit Price (Rs) 2,289.00 |
Gain (Rs) 13.00 |
sell Escorts Jun Fut |
Entry Price (Rs) 880.00 |
Exit Price (Rs) 874.45 |
Gain (Rs) 6.00 |
| Days | BSE | NSE |
| 30 | 2429.95 | 2430.30 |
| 50 | 2480.50 | 2480.27 |
| 150 | 2603.02 | 2603.66 |
| 200 | 2627.92 | 2628.08 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Piramal Enter
| Standalone | Mar'18 | Dec'17 | Sep'17 | Jun'17 |
| Net Sales | 1,003.01 | 871.06 | 802.25 | 612.31 |
| Other Income | 261.90 | 26.73 | 177.90 | 173.26 |
| PBDIT | 416.15 | 347.52 | 314.18 | 136.94 |
| Net Profit | 245.11 | 81.05 | 150.66 | 41.65 |
(In Rs Cr)
| Total Share Capital | 34.51 |
| Net Worth | 14,422.60 |
| Total Debt | 7,759.64 |
| Net Block | 1,074.80 |
| Investments | 17,274.21 |
| Total Assets | 21,580.38 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 576.30 | 3.91 | 608.55 | 433.15 | 138,273.07 |
| Cipla | 614.00 | 2.05 | 663.00 | 508.10 | 49,438.74 |
| Piramal Enter | 2602.35 | 2.48 | 3009.29 | 2279.05 | 46,996.49 |
| Cadila Health | 410.55 | -0.15 | 554.20 | 341.65 | 42,029.75 |
| Lupin | 904.90 | 0.67 | 1176.00 | 723.55 | 40,910.81 |
| More » | |||||
| Mar' 18 | Mar' 18 | Dec' 17 | Sep' 17 | |
| Promoter | 51.38 | 51.39 | 51.34 | 51.41 |
| Public (FII + DII) | 47.73 | 47.71 | 47.75 | 47.53 |
| Others | 0.89 | 0.90 | 0.91 | 1.06 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Canara Robeco Emerging Equities (G) | 292,837 |
| Aditya Birla Sun Life Arbitrage Fund - Direct Plan (G) | 116,973 |
| Invesco India Multicap Fund (G) | 80,048 |
| Tata Large & Mid Cap Fund - Regular Plan (G) | 62,974 |
IndusInd Bank Recommended on May 5th 2017
Recommended price 1,423.00 | Peak from reco 1990.00 39.83%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Piramal Enter
Piramal Enter is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 46,996.49 crore.
The company management includes Ajay Piramal - Chairman, Swati Piramal - Vice Chairperson, Nandini Piramal - Executive Director, Vijay Shah - Executive Director, Anand Piramal - Non Executive Director, Siddharth (Bobby) Mehta - Independent Director, Narayanan Vaghul - Independent Director, Deepak M Satwalekar - Independent Director, Keki Dadiseth - Independent Director, Gautam Banerjee - Independent Director, S Ramadorai - Independent Director, Goverdhan Mehta - Independent Director, Raghunath Mashelkar - Independent Director.
It is listed on the BSE with a BSE Code of 500302 and the NSE with an NSE Code of PEL.
Its Registered office is at Piramal Tower, Ganpatrao Kadam Marg,,Lower Parel, Mumbai,Maharashtra - 400013.
Their Registrars are Link Intime India Pvt. Ltd.
